evismo closes CHF 1 million seed financing round from Zühlke Ventures AG and angel investors.
evismo, a Zurich, Switzerland-based developer of a healthtech solution used for prevention, diagnosis and therapy via remote monitoring, announced that it closed a CHF 1 million ($1.1M) seed financing round.
The money was raised from Zühlke Ventures AG and angel investors, including members of the Swiss Health Angels and Business Angels Switzerland.
Jochen Ganz, entrepreneur and investor, and Tero Pasanen, Sales Director Bittium, are new members of the evismo AG Board of Directors.
The proceeds will be used to scale evismo’s business model, 'Diagnostics-as-a-Service' for patients and doctors.
evismo, founded in 2018 by CEO Willemien van den Toorn, provides diagnostics services that for patients with cardiac arrhythmias in Switzerland.